The role of androgen receptors in triple-negative breast cancer is particularly relevant because androgen receptor–positive triple-negative breast cancer is associated with reduced sensitivity to conventional systemic therapies but may respond to antiandrogenic treatments.51 The gene discussed is AR; the disease is triple-negative breast carcinoma.